Pfizer Deal Marks A Missed Chance For Branded-Drug Cos.
By settling a Tenth Circuit challenge to its victory in an antidepressant suicide-warning case Friday, Pfizer Inc. may have forfeited the pharmaceutical industry's best shot at advancing the finding that federal...To view the full article, register now.
Already a subscriber? Click here to view full article